CIK 1822947
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 93.35% | 20 |
| Unclassified | 6.65% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines, Inc. | Health Care | 10.50% |
| 2 | NERV | Minerva Neurosciences, Inc. | Health Care | 9.91% |
| 3 | SOLENO THERAPEUTICS INC | Unclassified | 6.65% | |
| 4 | OVID | Ovid Therapeutics Inc. | Health Care | 6.22% |
| 5 | CMPS | COMPASS Pathways plc | Health Care | 5.74% |
| 6 | TARS | Tarsus Pharmaceuticals, Inc. | Health Care | 5.64% |
| 7 | SLDB | Solid Biosciences Inc. | Health Care | 5.49% |
| 8 | PMN | ProMIS Neurosciences Inc. | Health Care | 5.23% |
| 9 | EWTX | Edgewise Therapeutics, Inc. | Health Care | 5.04% |
| 10 | EPRX | EUPRAXIA PHARMACEUTICALS INC. | Health Care | 4.75% |
20/21 names classified · sector 93.3% of weight · industry 93.3% · mkt cap 85.5%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 93.3% of the book is sector-classified (unclassified names shown, never dropped).
Only 3% of book weight classified — the grid is NOT representative of the whole book.
Classified: 2.8% of book weight (1/21 names) · unclassified 97.2%: PRAX, NERV, , OVID, CMPS, TARS, SLDB, PMN, EWTX, EPRX +10 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PRAXPRAXIS PRECISION MEDICINES I | 32,810 | $11M | 10.5% | ADD 65% |
| 2 | NERVMINERVA NEUROSCIENCES INC | 1,655,500 | $10M | 9.9% | HOLD |
| 3 | SOLENO THERAPEUTICS INC | 200,000 | $7M | 6.7% | ADD 19% |
| 4 | OVIDOVID THERAPEUTICS INC | 2,818,459 | $6M | 6.2% | ADD 58% |
| 5 | CMPSCOMPASS PATHWAYS PLC | 1,045,000 | $6M | 5.7% | NEW |
| 6 | TARSTARSUS PHARMACEUTICALS INC | 80,859 | $6M | 5.6% | NEW |
| 7 | SLDBSOLID BIOSCIENCES INC | 766,974 | $6M | 5.5% | ADD 85% |
| 8 | PMNPROMIS NEUROSCIENCES INC | 414,219 | $5M | 5.2% | ADD 66% |
| 9 | EWTXEDGEWISE THERAPEUTICS INC | 161,000 | $5M | 5.0% | TRIM −17% |
| 10 | EPRXEupraxia Pharmaceuticals Inc | 660,375 | $5M | 4.7% | ADD 66% |
| 11 | CTMXCYTOMX THERAPEUTICS INC. | 900,000 | $4M | 4.2% | NEW |
| 12 | IVAINVENTIVA SA | 745,300 | $4M | 4.1% | TRIM −50% |
| 13 | CATXPERSPECTIVE THERAPEUTICS INC | 926,557 | $4M | 3.8% | NEW |
| 14 | ABVXABIVAX SA | 33,712 | $4M | 3.7% | TRIM −52% |
| 15 | ALMSALUMIS INC | 166,959 | $4M | 3.7% | NEW |
| 16 | URGNUROGEN PHARMA LTD | 202,124 | $4M | 3.6% | NEW |
| 17 | CAPRCAPRICOR THERAPEUTICS INC | 113,899 | $3M | 3.4% | NEW |
| 18 | WHWKWHITEHAWK THERAPEUTICS INC | 817,939 | $3M | 2.8% | HOLD |
| 19 | IKTINHIBIKASE THERAPEUTICS INC | 1,325,000 | $2M | 2.2% | NEW |
| 20 | ANTXAN2 THERAPEUTICS INC | 526,315 | $2M | 1.8% | NEW |
| 21 | RLMDRELMADA THERAPEUTICS INC | 210,525 | $1M | 1.5% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| PRAXPRAXIS PRECISION MEDICINES I | 45K | 96K | 81K | — | 20K | 33K | $11M |
| NERVMINERVA NEUROSCIENCES INC | — | — | — | — | 1.7M | 1.7M | $10M |
| SOLENO THERAPEUTICS INC | 88K | 120K | 179K | 302K | 168K | 200K | $7M |
| OVIDOVID THERAPEUTICS INC | — | — | — | — | 1.8M | 2.8M | $6M |
| CMPSCOMPASS PATHWAYS PLC | — | — | 1.5M | 1.0M | — | 1.0M | $6M |
| TARSTARSUS PHARMACEUTICALS INC | 173K | 128K | 121K | 71K | — | 81K | $6M |
| SLDBSOLID BIOSCIENCES INC | — | — | 724K | 549K | 414K | 767K | $6M |
| PMNPROMIS NEUROSCIENCES INC | — | — | — | — | 249K | 414K | $5M |
| EWTXEDGEWISE THERAPEUTICS INC | 83K | 103K | — | — | 195K | 161K | $5M |
| EPRXEupraxia Pharmaceuticals Inc | — | — | — | 915K | 398K | 660K | $5M |
| CTMXCYTOMX THERAPEUTICS INC. | — | — | — | — | — | 900K | $4M |
| IVAINVENTIVA SA | — | — | — | — | 1.5M | 745K | $4M |
| CATXPERSPECTIVE THERAPEUTICS INC | — | — | — | — | — | 927K | $4M |
| ABVXABIVAX SA | — | — | — | — | 70K | 34K | $4M |
| ALMSALUMIS INC | 445K | — | — | — | — | 167K | $4M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
